headache; arm still sore; small raised bump on arm where vaccine given; Within 1 hour swelling on left arm where vaccine given; Sore to point of uncomfortable to lift arm; Sore to point of uncomfortable to lift arm; Became tired to point of yawning within 4 hours of vaccine/very tired; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 40-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 06Jun2022 at 10:30 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 40 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "asthma" (unspecified if ongoing); "Allergy: farm raised fish" (unspecified if ongoing); "Venous insufficiency in both legs" (unspecified if ongoing); "heart murmur" (unspecified if ongoing); "Allergy: strawberries" (unspecified if ongoing); "Allergy: straw hats and hand bags" (unspecified if ongoing). Concomitant medication(s) included: CLARITIN [GLICLAZIDE]; FLONASE [FLUTICASONE PROPIONATE]; FLOVENT; SINGULAIR; ALBUTEROL [SALBUTAMOL]; THORNE BIOMINS II. Vaccination history included: BNT162b2 (DOSE 1, SINGLE; Site of injection: Arm Left; Vaccine Administration Time: 08:00 AM), administration date: 19Feb2021, when the patient was 38-year-old, for Covid-19 immunisation; BNT162b2 (DOSE 2, SINGLE; Site of injection: Arm Left; Vaccine Administration Time: 08:00 AM), administration date: 12Mar2021, when the patient was 38-year-old, for Covid-19 immunisation; BNT162b2 (DOSE 3, SINGLE; Site of injection: Arm Left; Vaccine Administration Time: 10:00 AM), administration date: 13Oct2021, when the patient was 39-year-old, for Covid-19 immunisation, reaction(s): "lymph nodes in under arm both sides swollen/raised bump", "Tired", "Vaccination site swelling", "Vaccination site nodule", "uncomfortable to lift arm". The following information was reported: FATIGUE (non-serious) with onset 06Jun2022, outcome "not recovered", described as "Became tired to point of yawning within 4 hours of vaccine/very tired"; VACCINATION SITE PAIN (non-serious), VACCINATION SITE MOVEMENT IMPAIRMENT (non-serious) all with onset 06Jun2022, outcome "not recovered" and all described as "Sore to point of uncomfortable to lift arm"; VACCINATION SITE SWELLING (non-serious) with onset 06Jun2022 at 11:30, outcome "not recovered", described as "Within 1 hour swelling on left arm where vaccine given"; PAIN IN EXTREMITY (non-serious) with onset 07Jun2022, outcome "not recovered", described as "arm still sore"; HEADACHE (non-serious) with onset 07Jun2022, outcome "not recovered"; VACCINATION SITE NODULE (non-serious) with onset 07Jun2022, outcome "not recovered", described as "small raised bump on arm where vaccine given". Therapeutic measures were taken as a result of vaccination site swelling, vaccination site pain, vaccination site movement impairment, fatigue, headache, pain in extremity, vaccination site nodule.  Additional information: This case was reported as non-serious. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Within 1 hour swelling on left arm where vaccine given. Sore to point of uncomfortable to lift arm. Became tired to point of yawning within 4 hours of vaccine. Day 2 woke up with headache and very tired, arm still sore and small raised bump on arm where vaccine given. The patient received Tylenol, used ice packs for treatment. Same reactions from other booster. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.